NEW YORK--Cognia Bioinformatics, a privately held firm founded here in 1998, has announced that it will become the exclusive distributor in the US and Canada of an annotated database of transcription regulation information created by Biobase Biological Databases of Braunschweig, Germany. Biobase's Transfac database contains functional annotations of close to 2,500 transcription factors and 8,000 corresponding binding sites. Biobase said it has licensed Transfac to four large undisclosed pharmaceutical companies since the product was commercialized in November 1997. Bruno Larvol, Cognia's founder and CEO, who was previously a bioinformatics consultant at the Wilkerson Group, said, "Our market research suggests that the Transfac database has the potential to become an essential part of the bioinformatics toolkit for all major drug discovery companies."
Cognia, Biobase Partner To Distribute Database To Pharma, Biotech Markets
Jan 14, 1999